Predicting and Preparing for Disruption in Medtech

Session Description: Disruptive technology has been on the rise and with the current circumstances, adopting remote interaction in healthcare is critical to meet the needs of patients and consumers. Product redesign, virtual consultation and programming, and software are providing more opportunities in healthcare than ever before. To remain competitive, it’s imperative to recognize the changing opportunities, protect your IP, and do so with variable market demands.

In this session, we will discuss:

• Increased patient interaction with the medical devices and digital platforms and what changes are being made to adapt to remote interaction and what IP makes the most sense to protect them
• Medical device developments in the world of COVID-19
• Disruptive technology, related digital platforms/apps, and software as a medical device
• IP specific strategies to help overcome potential hurdles in protecting new innovations
• Market trends that affect IP risk assessments

Panelists: 

• Cory Bell, Partner, Finnegan
• Timothy McAnulty, Partner, Finnegan
• Eric Raciti, Partner, Finnegan
• Mita Chaterjee, Corporate Council, IP, Hologic, Inc.
• Holly Logue, Esq, Head of Strategic Assets and General Counsel, Drawbridge Health

Sponsored By: